Moderna Submits Request for Emergency Use of COVID-19 Vaccine for Young Children
The KidCOVE study included children 6 months to less than 6 years of age who received either two 25mcg doses of mRNA-1273 or placebo, separated by 28 days.
Vaccines
Israel Will Give Fourth COVID-19 Shot to People Aged Over 60 Years, Health Workers
About 60 percent of Israel’s 9.4 million people are fully vaccinated with either a recent second dose or booster dose
No Effect on Ovarian Reserve Seen After mRNA COVID-19 Vaccination
Mean levels of anti-Müllerian hormone unchanged from baseline to three months after vaccination among reproductive-aged women
Vaccinated Kidney Transplant Recipients Vulnerable to SARS-CoV-2 Variants
After two-dose vaccination, only 64 and 67 percent of kidney transplant recipients showed neutralization against B.1.351 (β) and B.1.617.2 (δ)
BNT162b2 Vaccine Effectiveness 92% for Teens Aged 12 to 17 Years
Estimated vaccine effectiveness of full Pfizer-BioNTech vaccination 92 percent for preventing SARS-CoV-2 infection
NVX-CoV2373 Vaccine Protects Against COVID-19
Study conducted in the U.S. and Mexico shows vaccine 90 percent effective overall, 100 percent effective against moderate-to-severe disease
FDA Approves Pfizer Booster Shots for Children Aged 12 to 15 Years
Agency also reduced the period people must wait between their second dose and booster shot from six to five months
mRNA COVID-19 Vaccine Less Protective in Elderly With Comorbidity
At ≥7 days after second dose, effectiveness of mRNA COVID-19 vaccine was 69 percent against infection, 86 percent against related death
COVID-19 Certification Mandates May Increase Vaccine Uptake
Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates
FDA Gives OK to Merck Antiviral At-Home COVID-19 Pill
Molnupiravir cut the risk for hospitalization and death in high-risk patients by 30 percent
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...